ACHV Similar Chart Price Prediction
The price of ACHV is predicted to go up -10.23%, based on the high correlation periods with PARR. The similarity of these two price pattern on the periods is 90.3%.
ACHV
PARR
Down: -10.23%Similarity: 90.3%
ACHV Revenue Forecast
ACHV EPS Forecast
ACHV Analyst's Forecast
Brandon Folkes
Rodman & Renshaw
Strong Buy
2024-11-14
Price Target
$12
Upside
+167.26%
Rodman & Renshaw initiated coverage of Achieve Life Sciences with a Buy rating and $12 price target. Achieve is dedicated to addressing the global smoking and nicotine addiction crisis by developing and commercializing cytisinicline, the analyst tells investors in a research note. The firm says the company is poised to address the lack of FDA-approved treatments for e-cigarette cessation, further expanding the potential impact of cytisinicline in combating nicotine addiction.
Gary Nachman
Raymond James
Strong Buy
2024-09-27
Price Target
$20
Upside
+289.11%
